Pro Dex Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pro Dex Inc's ROI in the fourth quarter of 2026?
Pro dex Inc achieved a return on average invested assets (ROI) of 24.56 % in its fourth quarter of 2026, this is above PDEX's average return on investment of 12.94%.
Pro Dex Inc invested over the 12 months ending in its fourth quarter of 2026 $56 million

Despite the deterioration in its net income, company has improved ROI compared to the third quarter of 2026.

Within the Healthcare sector 39 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 253, from total ROI ranking in the third quarter of 2026 at 260.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Investment Change TTM	13.1 %	38.76 %	34.11 %	26 %	21.46 %
Y / Y Net Income Change TTM	52.17 %	28.12 %	86.1 %	176.14 %	465.72 %
Investment (TTM) in Millions	66	60	47	50	71
Return On Investment (TTM)	24.56 %	21.11 %	21.29 %	21.85 %	18.25 %
PDEX's Overall Ranking	# 253	# 260	# 217	# 248	# 267
Seq. Investment Change TTM	-2.17 %	6.74 %	3.98 %	4.16 %	20.03 %
Seq. Net Income Change TTM	13.83 %	5.85 %	1.31 %	24.66 %	-4.16 %
Net Income (TTM) in Millions	14	12	11	11	9

PDEX Company Profile >> Back to PDEX Roi Comparisons >> See Annual PDEX Return On Investment

Return On Investment PDEX's Ranking
Within:	No.
Industry	# 6
Sector	# 40
Overall	# 253

Return On Investment Statistics
High	Average	Low
45.05 %	12.94 %	-18.6 %
(Mar 31 2017)		(Jun 30 2013)

Financial Statements
Pro Dex Inc's IV. Quarter Investments	$ 66 Millions	PDEX's Balance sheet
Pro Dex Inc's IV. Quarter Income	$ 3 Millions	Quarterly PDEX's Income Statement
PDEX's Income by Division		See PDEX's Income by Division

PDEX Annual Return On Investment	(Jun 30 2026) 2026	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022
Total Investments in Millions	66	47	38	42	34
Y / Y Investment Growth	42.41 %	21.25 %	-8.88 %	24.26 %	5.94 %
Net Income in Millions	14	9	2	7	4
Y / Y Net Income Growth	52.17 %	322.1 %	-69.93 %	83.5 %	-13.37 %
Annual Return On Investment	20.6 %	19.28 %	5.54 %	16.78 %	11.37 %

Annual Roi Comment

In the fiscal year 2026 ROI improved to 20.6 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PDEX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PDEX's Competitors
Subscribers only: Roi for Pro Dex Inc's Suppliers
Subscribers only: Return On Investment for PDEX's Customers

Other Ratios
PDEX's Roa	PDEX's Inventory Turnover Ratio	PDEX's Growth Rates	PDEX's Dividend Statistics
	PDEX's Profitability Ratios	PDEX's Asset Turnover Ratio	PDEX's Dividend Growth
PDEX's Roe	PDEX's Valuation Ratios	PDEX's Financial Strength Ratios	PDEX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Earth Science Tech Inc	64.38 %
Meiragtx Holdings Plc	55.83 %
Elite Pharmaceuticals Inc	53.48 %
Idexx Laboratories Inc	51.80 %
Aurinia Pharmaceuticals Inc	50.35 %
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %
Tg Therapeutics Inc	39.26 %
Medpace Holdings Inc	35.54 %
Mettler toledo International Inc	34.41 %
Eli Lilly And Company	33.95 %
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %
Innoviva Inc	23.33 %
Electromed Inc	23.18 %
Zevra Therapeutics Inc	22.90 %
Iradimed Corporation	22.57 %
Alnylam Pharmaceuticals Inc	22.10 %
Eton Pharmaceuticals Inc	21.31 %
Dexcom Inc	20.98 %
Healthcare Services Group Inc	20.93 %
Arcutis Biotherapeutics Inc	20.77 %
Chemed Corporation	20.13 %
Resmed Inc	20.01 %
Halozyme Therapeutics Inc	19.99 %

Date modified: 2026-09-05T07:51:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.